Consolidated Statements of Cash Flows (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Supplemental disclosures of non-cash transactions:
Patent costs accrued from Auxilium	$ 318,280
Patent amortizations expenses	50,685	36,041	33,983
Net patent amortization expense due to a reduction of reimbursable patents fees under our agreement with Auxilium		$ 18,339